PSNC sets up Community Pharmacy Brexit Forum

PSNC sets up Community Pharmacy Brexit Forum

July 27 2018 Chief executives of representative bodies involved in community pharmacy and the...

Boots and PDA discuss union recognition, but no agreement as yet

Boots and PDA discuss union recognition, but no agreement as yet

July 26 2018 The Pharmacists’ Defence Association has been holding talks with members of...

Appeal process for overpayment recovery by NHS England to start in August

Appeal process for overpayment recovery by NHS England to start in August

July 26 2018 New regulations introducing an appeals process to challenge NHS England recovering...

MPs hear about community pharmacy role in LTC management

MPs hear about community pharmacy role in LTC management

July 20 2018 Community pharmacy representatives have briefed MPs about the role pharmacy teams...

MHRA launches consultation on implementing FMD safety features

MHRA launches consultation on implementing FMD safety features

July 20 2018 A consultation asking for views on how the safety features required under the...

  • PSNC sets up Community Pharmacy Brexit Forum

    PSNC sets up Community Pharmacy Brexit Forum

    Friday, 27 July 2018 16:04
  • Boots and PDA discuss union recognition, but no agreement as yet

    Boots and PDA discuss union recognition, but no agreement as yet

    Thursday, 26 July 2018 15:19
  • Appeal process for overpayment recovery by NHS England to start in August

    Appeal process for overpayment recovery by NHS England to start in August

    Thursday, 26 July 2018 15:04
  • MPs hear about community pharmacy role in LTC management

    MPs hear about community pharmacy role in LTC management

    Friday, 20 July 2018 16:30
  • MHRA launches consultation on implementing FMD safety features

    MHRA launches consultation on implementing FMD safety features

    Friday, 20 July 2018 14:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

A Resized Pharmacy Image cbOctober 4 2017

New guidance on the Pharmacy Quality Payments scheme has been published ahead of the November declaration process.

 NHS England’s new guidance document “considers the learning following the April declaration, the validation procedures and the subsequent modifications that have been made to processes for the November declaration,” said PSNC. “It also clarifies the requirements for meeting the gateway and quality criteria, completing the November declaration process and where possible, the evidence required to meet the validation procedures.”

All declarations for the November 24 2017 review dates must be made online via the NHS Business Services website, said NHS England. This will open on November 13 and close on December 8 2017.

The scheme is intended to “reward community pharmacies for delivering quality criteria in all three of the quality dimensions: clinical effectiveness, patient safety and patient experience.” Since April 2017, over 94% of pharmacies in England (11,094 out of around 11,700) have made claims with 10,985 being eligible for a payment.

Up to £75 million has been made available to community pharmacies in England qualifying for the scheme which started on December 1 2016 and runs to March 31 2018 initially.

“At the half year point, successes include an estimated 12,500 asthma patients at high risk of suffering a severe asthma attack being identified and referred for a full asthma review and greater awareness regarding the needs of people with dementia,” said NHS England.

“So far around 70,000 pharmacy staff in patient-facing roles have become Dementia Friends and other qualifying payments have been made for a range of digital improvements. These include updating all NHS Choices profiles on their opening times, services provided, such as chlamydia testing and screening, and facilities such as parking and disabled access.”

PSNC said it “strongly encourages all community pharmacy contractors to read the new NHS England guidance, as well as the previous guidance, to ensure they are fully briefed on the requirements of the Quality Payments Scheme.”

Rosie Taylor, PSNC’s Head of Service Development, has recorded a 30-minute presentation giving information on the changes that have been made for the November review point compared to the April review point as well as the key learning points to be aware of ahead of the November review point

PSNC has also flagged up the new NHS Pharmacy Directory of Service (DoS) Quality Payments “which community pharmacy contractors will need to use to meet the DoS quality criterion of the Quality Payments Scheme.”

PSNC has also noted the publication of declaration data for the April review point of the Quality Payments Scheme, published by NHS Business Service Authority (NHS BSA). The data provides a breakdown of the number of contractors who declared that they met the gateway criteria and the number of contractors who declared they met the individual quality criteria.

Alastair Buxton, Director of NHS Services at PSNC, said: “It is great to be able to see the breakdown of data from the April review point of the Quality Payments Scheme which shows the phenomenal engagement of pharmacy teams.”

Links:
NHS England announcement      
NHS England Pharmacy Quality Payments Scheme          
NHS England ‘Pharmacy Quality Payments – Guidance for the November 2017 Declaration’         
PSNC announcement about new PQP guidance    
PSNC Quality Payments Scheme webinar video   
PSNC statement on April declaration data publication    
PSNC Pharmacy DoS Quality announcement         

NHS Pharmacy DoS Quality Payments       https://dos-profile.service.nhs.uk/#/

Business News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...